Surface Ophthalmics has a total of 28 patents globally, out of which 2 have been granted. Of these 28 patents, more than 64% patents are active. The United States of America is where Surface Ophthalmics has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Surface Ophthalmics.
Surface Ophthalmics was founded in 2017. Surface Ophthalmics is a pharmaceutical company focused on the research and marketing of novel medicines for ocular diseases. The company’s objective is to address significant patient needs related to eye care through using its extensive experience, audacious strategy, efficiency-focused mind-set, and distinct, obvious therapeutic advantages.
Do read about some of the most popular patents of Surface Ophthalmics which have been covered by us in this article and also you can find Surface Ophthalmics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Surface Ophthalmics patent portfolio.
How many patents does Surface Ophthalmics have?
Surface Ophthalmics has a total of 28 patents globally. These patents belong to 3 unique patent families. Out of 28 patents, 18 patents are active.
How Many Patents did Surface Ophthalmics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Surface Ophthalmics Applications Filed | Surface Ophthalmics Patents Granted |
| 2023 | 3 | 2 |
| 2022 | 2 | – |
| 2021 | 4 | – |
| 2019 | 10 | – |
| 2018 | 3 | – |
| 2017 | 1 | – |
| 2016 | 5 | – |
How many Surface Ophthalmics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Surface Ophthalmics File in Different Countries?
Countries in which Surface Ophthalmics Filed Patents
| Country | Patent |
| United States Of America | 8 |
| Europe | 3 |
| Canada | 2 |
| Australia | 2 |
| Brazil | 1 |
| Singapore | 1 |
| Mexico | 1 |
| South Africa | 1 |
| China | 1 |
| Japan | 1 |
| Korea (South) | 1 |
| Israel | 1 |
Where are Research Centers of Surface Ophthalmics Patents Located?
The Research Centers of SurfaceOphthalmics Patents is the United States of America.
10 Best Surface Ophthalmics Patents
WO2020139525A1 is the most popular patent in the Surface Ophthalmics portfolio and it has received 3 citations.
Below is the list of 10 most cited patents of Surface Ophthalmics:
| Publication Number | Citation Count |
| WO2020139525A1 | 3 |
| WO2019060696A1 | 2 |
| WO2022240598A1 | 1 |
| US20170165280A1 | 1 |
List of Surface Ophthalmics patents
| Surface Ophthalmics Patents | Title |
| US11766421B2 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| US20230277557A1 | Pharmaceutical Kits And Their Use For Treating Dry Eye Disease |
| US20230158045A1 | Pharmaceutical Compositions Of Mycophenolic Acid And/Or Betamethasone For The Treatment Of Ocular Disorders |
| US20220143075A1 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| US20220071945A1 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| EP3902525A4 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| EP3691654A4 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| CN113473970A | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| WO2023141334A3 | Pharmaceutical Compositions Of Mycophenolic Acid And/Or Betamethasone For The Treatment Of Ocular Disorders |
| WO2022240598A1 | Use Of Chondroitin Sulfate For Relieving Ocular Pain |
| JP2022516099A5 | Ophthalmic Pharmaceutical Composition And Treatment Method For Cancer Surface Diseases |
| IL284344A | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| SG11202106967QA | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| AU2019417161B2 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| MX2021007709A | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease. |
| CA3124945A1 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| BR112021012492A2 | Ophthalmic Pharmaceutical Compositions And Methods For Treatment Of Ocular Surface Disease |
| ZA202104405A | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| US20190151338A1 | Pharmaceutical Formulations For Treating Skin Disorders And Methods For Fabricating And Using Thereof |
| US20170326161A1 | Pharmaceutical Formulations For Treating Skin Disorders And Methods For Fabricating And Using Thereof |
| US20170165280A1 | Pharmaceutical Formulations For Treating Skin Disorders And Methods For Fabricating And Using Thereof |
| EP3386516A4 | Pharmaceutical Formulations For Treating Skin Disorders And Methods For Fabricating And Using Thereof |
| WO2022076398A1 | Pharmaceutical Kits And Their Use For Treating Dry Eye Disease |
| WO2020139525A1 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| WO2019060696A1 | Ophthalmic Pharmaceutical Compositions And Methods For Treating Ocular Surface Disease |
| AU2016368299A1 | Pharmaceutical Formulations For Treating Skin Disorders And Methods For Fabricating And Using Thereof |
| CA3008039A1 | Pharmaceutical Formulations For Treating Skin Disorders And Methods For Fabricating And Using Thereof |
| KR1020180085033A | Pharmaceutical Formulations For Treating Skin Disorders And Methods For Fabricating And Using Thereof |
What are Surface Ophthalmics key innovation segments?
What Technologies are Covered by Surface Ophthalmics?
The chart below distributes patents filed by Surface Ophthalmics